← Leaderboards
Matthew B Veldman
Medical College Of Wisconsin
$1,564,295
Attributed
$1,564,295
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $419.7K · FY2022–25$500K$375K$250K$125K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$1,564,295 · 1
By mechanism
R01$1,564,295 · 1
Top collaborators
No co-investigators on record.
Most similar at Medical College Of Wisconsin
Same institution · by research overlap
- Balaraman Kalyanaraman$20,398,607
- Marilyn P Merker$1,634,964
- Michaela Patterson$2,963,140
- Ze Zheng$2,576,571
- Pui Ying Lam$2,067,716
Others in their field
Other Rising Stars on “Optic Nerve Regeneration”
- Shane Liddelow · New York University School Of Medicine$2,023,416
- Tasneem Putliwala Sharma · Indiana University Indianapolis$783,492
- Philip Raymond Williams · Boston Children'S Hospital$640,426
- Fang Chen · Stanford University$552,692
- Anna Jagielska · Artificial Axon Labs Inc.$506,083
- Yuqin Yin · Boston Children'S Hospital$486,750
Research focus
Optic Nerve RegenerationPathway InteractionsRegulationMevalonateCholesterolAntagonistAnimalsAffectBiologicalAxon RegenerationBlindnessBrainCell InjuryCellsAcuteAxon InjuryDifferential ExpressionAxonCholesterol TraffickingCoenzyme Q10CostCritical PeriodData SetCell Survival
Grant awards (5)
Regulation of successful optic nerve regeneration by the mevalonate/cholesterol pathway$351,000
R01 · FY2025 · EY · contact PI
Regulation of successful optic nerve regeneration by the mevalonate/cholesterol pathway$351,000
R01 · FY2024 · EY · contact PI
Regulation of successful optic nerve regeneration by the mevalonate/cholesterol pathway$68,673
R01 · FY2024 · EY · contact PI
Regulation of successful optic nerve regeneration by the mevalonate/cholesterol pathway$389,810
R01 · FY2023 · EY · contact PI
Regulation of successful optic nerve regeneration by the mevalonate/cholesterol pathway$403,812
R01 · FY2022 · EY · contact PI